Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2024-2030

Page: 147

Published Date: 19 Nov 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines. Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report studies the global Recombinant Coagulation Factor Concentrate production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Coagulation Factor Concentrate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Coagulation Factor Concentrate that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Coagulation Factor Concentrate total production and demand, 2019-2030, (K Units)
Global Recombinant Coagulation Factor Concentrate total production value, 2019-2030, (USD Million)
Global Recombinant Coagulation Factor Concentrate production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Recombinant Coagulation Factor Concentrate consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Recombinant Coagulation Factor Concentrate domestic production, consumption, key domestic manufacturers and share
Global Recombinant Coagulation Factor Concentrate production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Recombinant Coagulation Factor Concentrate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL, Baxalta, Sanofi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Coagulation Factor Concentrate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Recombinant Coagulation Factor Concentrate Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Coagulation Factor Concentrate Market, Segmentation by Type:
    250 IU
    500 IU
    1000 IU
    2000 IU

Global Recombinant Coagulation Factor Concentrate Market, Segmentation by Application:
    Hopistial
    Clinic
    Others

Companies Profiled:
    Bayer
    Alprolix
    Benefix
    Idelvion
    Lxinity
    Rebinyn
    Rixubis
    CSL
    Baxalta
    Sanofi
    Biogen
    Pfizer
    Novo Disk
    Baxter
    Wyeth
    Beijing Tiantan Biological Products
    SHANGHAI RAAS
    Taibang Biologic Group
    HUALAN BIOLOGICAL ENGINEERING
    Green Cross

Key Questions Answered:
1. How big is the global Recombinant Coagulation Factor Concentrate market?
2. What is the demand of the global Recombinant Coagulation Factor Concentrate market?
3. What is the year over year growth of the global Recombinant Coagulation Factor Concentrate market?
4. What is the production and production value of the global Recombinant Coagulation Factor Concentrate market?
5. Who are the key producers in the global Recombinant Coagulation Factor Concentrate market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Coagulation Factor Concentrate Introduction
    1.2 World Recombinant Coagulation Factor Concentrate Supply & Forecast
        1.2.1 World Recombinant Coagulation Factor Concentrate Production Value (2019 & 2023 & 2030)
        1.2.2 World Recombinant Coagulation Factor Concentrate Production (2019-2030)
        1.2.3 World Recombinant Coagulation Factor Concentrate Pricing Trends (2019-2030)
    1.3 World Recombinant Coagulation Factor Concentrate Production by Region (Based on Production Site)
        1.3.1 World Recombinant Coagulation Factor Concentrate Production Value by Region (2019-2030)
        1.3.2 World Recombinant Coagulation Factor Concentrate Production by Region (2019-2030)
        1.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Region (2019-2030)
        1.3.4 North America Recombinant Coagulation Factor Concentrate Production (2019-2030)
        1.3.5 Europe Recombinant Coagulation Factor Concentrate Production (2019-2030)
        1.3.6 China Recombinant Coagulation Factor Concentrate Production (2019-2030)
        1.3.7 Japan Recombinant Coagulation Factor Concentrate Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Coagulation Factor Concentrate Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Coagulation Factor Concentrate Major Market Trends

2 Demand Summary
    2.1 World Recombinant Coagulation Factor Concentrate Demand (2019-2030)
    2.2 World Recombinant Coagulation Factor Concentrate Consumption by Region
        2.2.1 World Recombinant Coagulation Factor Concentrate Consumption by Region (2019-2024)
        2.2.2 World Recombinant Coagulation Factor Concentrate Consumption Forecast by Region (2025-2030)
    2.3 United States Recombinant Coagulation Factor Concentrate Consumption (2019-2030)
    2.4 China Recombinant Coagulation Factor Concentrate Consumption (2019-2030)
    2.5 Europe Recombinant Coagulation Factor Concentrate Consumption (2019-2030)
    2.6 Japan Recombinant Coagulation Factor Concentrate Consumption (2019-2030)
    2.7 South Korea Recombinant Coagulation Factor Concentrate Consumption (2019-2030)
    2.8 ASEAN Recombinant Coagulation Factor Concentrate Consumption (2019-2030)
    2.9 India Recombinant Coagulation Factor Concentrate Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Recombinant Coagulation Factor Concentrate Production Value by Manufacturer (2019-2024)
    3.2 World Recombinant Coagulation Factor Concentrate Production by Manufacturer (2019-2024)
    3.3 World Recombinant Coagulation Factor Concentrate Average Price by Manufacturer (2019-2024)
    3.4 Recombinant Coagulation Factor Concentrate Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Coagulation Factor Concentrate Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Coagulation Factor Concentrate in 2023
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Coagulation Factor Concentrate in 2023
    3.6 Recombinant Coagulation Factor Concentrate Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Coagulation Factor Concentrate Market: Region Footprint
        3.6.2 Recombinant Coagulation Factor Concentrate Market: Company Product Type Footprint
        3.6.3 Recombinant Coagulation Factor Concentrate Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Comparison
        4.1.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Comparison
        4.2.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Comparison
        4.3.1 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2019-2024)
    4.5 China Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share
        4.5.1 China Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2019-2024)
        4.5.3 China Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2019-2024)
    4.6 Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2019-2024)

5 Market Analysis by Type
    5.1 World Recombinant Coagulation Factor Concentrate Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 250 IU
        5.2.2 500 IU
        5.2.3 1000 IU
        5.2.4 2000 IU
    5.3 Market Segment by Type
        5.3.1 World Recombinant Coagulation Factor Concentrate Production by Type (2019-2030)
        5.3.2 World Recombinant Coagulation Factor Concentrate Production Value by Type (2019-2030)
        5.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Recombinant Coagulation Factor Concentrate Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hopistial
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Recombinant Coagulation Factor Concentrate Production by Application (2019-2030)
        6.3.2 World Recombinant Coagulation Factor Concentrate Production Value by Application (2019-2030)
        6.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Recombinant Coagulation Factor Concentrate Product and Services
        7.1.4 Bayer Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Alprolix
        7.2.1 Alprolix Details
        7.2.2 Alprolix Major Business
        7.2.3 Alprolix Recombinant Coagulation Factor Concentrate Product and Services
        7.2.4 Alprolix Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Alprolix Recent Developments/Updates
        7.2.6 Alprolix Competitive Strengths & Weaknesses
    7.3 Benefix
        7.3.1 Benefix Details
        7.3.2 Benefix Major Business
        7.3.3 Benefix Recombinant Coagulation Factor Concentrate Product and Services
        7.3.4 Benefix Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Benefix Recent Developments/Updates
        7.3.6 Benefix Competitive Strengths & Weaknesses
    7.4 Idelvion
        7.4.1 Idelvion Details
        7.4.2 Idelvion Major Business
        7.4.3 Idelvion Recombinant Coagulation Factor Concentrate Product and Services
        7.4.4 Idelvion Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Idelvion Recent Developments/Updates
        7.4.6 Idelvion Competitive Strengths & Weaknesses
    7.5 Lxinity
        7.5.1 Lxinity Details
        7.5.2 Lxinity Major Business
        7.5.3 Lxinity Recombinant Coagulation Factor Concentrate Product and Services
        7.5.4 Lxinity Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Lxinity Recent Developments/Updates
        7.5.6 Lxinity Competitive Strengths & Weaknesses
    7.6 Rebinyn
        7.6.1 Rebinyn Details
        7.6.2 Rebinyn Major Business
        7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Product and Services
        7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Rebinyn Recent Developments/Updates
        7.6.6 Rebinyn Competitive Strengths & Weaknesses
    7.7 Rixubis
        7.7.1 Rixubis Details
        7.7.2 Rixubis Major Business
        7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Product and Services
        7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Rixubis Recent Developments/Updates
        7.7.6 Rixubis Competitive Strengths & Weaknesses
    7.8 CSL
        7.8.1 CSL Details
        7.8.2 CSL Major Business
        7.8.3 CSL Recombinant Coagulation Factor Concentrate Product and Services
        7.8.4 CSL Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 CSL Recent Developments/Updates
        7.8.6 CSL Competitive Strengths & Weaknesses
    7.9 Baxalta
        7.9.1 Baxalta Details
        7.9.2 Baxalta Major Business
        7.9.3 Baxalta Recombinant Coagulation Factor Concentrate Product and Services
        7.9.4 Baxalta Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Baxalta Recent Developments/Updates
        7.9.6 Baxalta Competitive Strengths & Weaknesses
    7.10 Sanofi
        7.10.1 Sanofi Details
        7.10.2 Sanofi Major Business
        7.10.3 Sanofi Recombinant Coagulation Factor Concentrate Product and Services
        7.10.4 Sanofi Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Sanofi Recent Developments/Updates
        7.10.6 Sanofi Competitive Strengths & Weaknesses
    7.11 Biogen
        7.11.1 Biogen Details
        7.11.2 Biogen Major Business
        7.11.3 Biogen Recombinant Coagulation Factor Concentrate Product and Services
        7.11.4 Biogen Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Biogen Recent Developments/Updates
        7.11.6 Biogen Competitive Strengths & Weaknesses
    7.12 Pfizer
        7.12.1 Pfizer Details
        7.12.2 Pfizer Major Business
        7.12.3 Pfizer Recombinant Coagulation Factor Concentrate Product and Services
        7.12.4 Pfizer Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Pfizer Recent Developments/Updates
        7.12.6 Pfizer Competitive Strengths & Weaknesses
    7.13 Novo Disk
        7.13.1 Novo Disk Details
        7.13.2 Novo Disk Major Business
        7.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Product and Services
        7.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Novo Disk Recent Developments/Updates
        7.13.6 Novo Disk Competitive Strengths & Weaknesses
    7.14 Baxter
        7.14.1 Baxter Details
        7.14.2 Baxter Major Business
        7.14.3 Baxter Recombinant Coagulation Factor Concentrate Product and Services
        7.14.4 Baxter Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Baxter Recent Developments/Updates
        7.14.6 Baxter Competitive Strengths & Weaknesses
    7.15 Wyeth
        7.15.1 Wyeth Details
        7.15.2 Wyeth Major Business
        7.15.3 Wyeth Recombinant Coagulation Factor Concentrate Product and Services
        7.15.4 Wyeth Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Wyeth Recent Developments/Updates
        7.15.6 Wyeth Competitive Strengths & Weaknesses
    7.16 Beijing Tiantan Biological Products
        7.16.1 Beijing Tiantan Biological Products Details
        7.16.2 Beijing Tiantan Biological Products Major Business
        7.16.3 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product and Services
        7.16.4 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Beijing Tiantan Biological Products Recent Developments/Updates
        7.16.6 Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
    7.17 SHANGHAI RAAS
        7.17.1 SHANGHAI RAAS Details
        7.17.2 SHANGHAI RAAS Major Business
        7.17.3 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product and Services
        7.17.4 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 SHANGHAI RAAS Recent Developments/Updates
        7.17.6 SHANGHAI RAAS Competitive Strengths & Weaknesses
    7.18 Taibang Biologic Group
        7.18.1 Taibang Biologic Group Details
        7.18.2 Taibang Biologic Group Major Business
        7.18.3 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product and Services
        7.18.4 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Taibang Biologic Group Recent Developments/Updates
        7.18.6 Taibang Biologic Group Competitive Strengths & Weaknesses
    7.19 HUALAN BIOLOGICAL ENGINEERING
        7.19.1 HUALAN BIOLOGICAL ENGINEERING Details
        7.19.2 HUALAN BIOLOGICAL ENGINEERING Major Business
        7.19.3 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product and Services
        7.19.4 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.19.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments/Updates
        7.19.6 HUALAN BIOLOGICAL ENGINEERING Competitive Strengths & Weaknesses
    7.20 Green Cross
        7.20.1 Green Cross Details
        7.20.2 Green Cross Major Business
        7.20.3 Green Cross Recombinant Coagulation Factor Concentrate Product and Services
        7.20.4 Green Cross Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.20.5 Green Cross Recent Developments/Updates
        7.20.6 Green Cross Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Coagulation Factor Concentrate Industry Chain
    8.2 Recombinant Coagulation Factor Concentrate Upstream Analysis
        8.2.1 Recombinant Coagulation Factor Concentrate Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Coagulation Factor Concentrate Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Coagulation Factor Concentrate Production Mode
    8.6 Recombinant Coagulation Factor Concentrate Procurement Model
    8.7 Recombinant Coagulation Factor Concentrate Industry Sales Model and Sales Channels
        8.7.1 Recombinant Coagulation Factor Concentrate Sales Model
        8.7.2 Recombinant Coagulation Factor Concentrate Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Recombinant Coagulation Factor Concentrate Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Recombinant Coagulation Factor Concentrate Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Recombinant Coagulation Factor Concentrate Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2019-2024)
 Table 5. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2025-2030)
 Table 6. World Recombinant Coagulation Factor Concentrate Production by Region (2019-2024) & (K Units)
 Table 7. World Recombinant Coagulation Factor Concentrate Production by Region (2025-2030) & (K Units)
 Table 8. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2019-2024)
 Table 9. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2025-2030)
 Table 10. World Recombinant Coagulation Factor Concentrate Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Recombinant Coagulation Factor Concentrate Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Recombinant Coagulation Factor Concentrate Major Market Trends
 Table 13. World Recombinant Coagulation Factor Concentrate Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Recombinant Coagulation Factor Concentrate Consumption by Region (2019-2024) & (K Units)
 Table 15. World Recombinant Coagulation Factor Concentrate Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Recombinant Coagulation Factor Concentrate Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Recombinant Coagulation Factor Concentrate Producers in 2023
 Table 18. World Recombinant Coagulation Factor Concentrate Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Recombinant Coagulation Factor Concentrate Producers in 2023
 Table 20. World Recombinant Coagulation Factor Concentrate Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Recombinant Coagulation Factor Concentrate Company Evaluation Quadrant
 Table 22. World Recombinant Coagulation Factor Concentrate Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Recombinant Coagulation Factor Concentrate Production Site of Key Manufacturer
 Table 24. Recombinant Coagulation Factor Concentrate Market: Company Product Type Footprint
 Table 25. Recombinant Coagulation Factor Concentrate Market: Company Product Application Footprint
 Table 26. Recombinant Coagulation Factor Concentrate Competitive Factors
 Table 27. Recombinant Coagulation Factor Concentrate New Entrant and Capacity Expansion Plans
 Table 28. Recombinant Coagulation Factor Concentrate Mergers & Acquisitions Activity
 Table 29. United States VS China Recombinant Coagulation Factor Concentrate Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Recombinant Coagulation Factor Concentrate Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Recombinant Coagulation Factor Concentrate Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2019-2024)
 Table 37. China Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2019-2024)
 Table 42. Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2019-2024)
 Table 47. World Recombinant Coagulation Factor Concentrate Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Recombinant Coagulation Factor Concentrate Production by Type (2019-2024) & (K Units)
 Table 49. World Recombinant Coagulation Factor Concentrate Production by Type (2025-2030) & (K Units)
 Table 50. World Recombinant Coagulation Factor Concentrate Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Recombinant Coagulation Factor Concentrate Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Recombinant Coagulation Factor Concentrate Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Recombinant Coagulation Factor Concentrate Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Recombinant Coagulation Factor Concentrate Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Recombinant Coagulation Factor Concentrate Production by Application (2019-2024) & (K Units)
 Table 56. World Recombinant Coagulation Factor Concentrate Production by Application (2025-2030) & (K Units)
 Table 57. World Recombinant Coagulation Factor Concentrate Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Recombinant Coagulation Factor Concentrate Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Recombinant Coagulation Factor Concentrate Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Recombinant Coagulation Factor Concentrate Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Bayer Basic Information, Manufacturing Base and Competitors
 Table 62. Bayer Major Business
 Table 63. Bayer Recombinant Coagulation Factor Concentrate Product and Services
 Table 64. Bayer Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Bayer Recent Developments/Updates
 Table 66. Bayer Competitive Strengths & Weaknesses
 Table 67. Alprolix Basic Information, Manufacturing Base and Competitors
 Table 68. Alprolix Major Business
 Table 69. Alprolix Recombinant Coagulation Factor Concentrate Product and Services
 Table 70. Alprolix Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Alprolix Recent Developments/Updates
 Table 72. Alprolix Competitive Strengths & Weaknesses
 Table 73. Benefix Basic Information, Manufacturing Base and Competitors
 Table 74. Benefix Major Business
 Table 75. Benefix Recombinant Coagulation Factor Concentrate Product and Services
 Table 76. Benefix Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Benefix Recent Developments/Updates
 Table 78. Benefix Competitive Strengths & Weaknesses
 Table 79. Idelvion Basic Information, Manufacturing Base and Competitors
 Table 80. Idelvion Major Business
 Table 81. Idelvion Recombinant Coagulation Factor Concentrate Product and Services
 Table 82. Idelvion Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Idelvion Recent Developments/Updates
 Table 84. Idelvion Competitive Strengths & Weaknesses
 Table 85. Lxinity Basic Information, Manufacturing Base and Competitors
 Table 86. Lxinity Major Business
 Table 87. Lxinity Recombinant Coagulation Factor Concentrate Product and Services
 Table 88. Lxinity Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Lxinity Recent Developments/Updates
 Table 90. Lxinity Competitive Strengths & Weaknesses
 Table 91. Rebinyn Basic Information, Manufacturing Base and Competitors
 Table 92. Rebinyn Major Business
 Table 93. Rebinyn Recombinant Coagulation Factor Concentrate Product and Services
 Table 94. Rebinyn Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Rebinyn Recent Developments/Updates
 Table 96. Rebinyn Competitive Strengths & Weaknesses
 Table 97. Rixubis Basic Information, Manufacturing Base and Competitors
 Table 98. Rixubis Major Business
 Table 99. Rixubis Recombinant Coagulation Factor Concentrate Product and Services
 Table 100. Rixubis Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Rixubis Recent Developments/Updates
 Table 102. Rixubis Competitive Strengths & Weaknesses
 Table 103. CSL Basic Information, Manufacturing Base and Competitors
 Table 104. CSL Major Business
 Table 105. CSL Recombinant Coagulation Factor Concentrate Product and Services
 Table 106. CSL Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. CSL Recent Developments/Updates
 Table 108. CSL Competitive Strengths & Weaknesses
 Table 109. Baxalta Basic Information, Manufacturing Base and Competitors
 Table 110. Baxalta Major Business
 Table 111. Baxalta Recombinant Coagulation Factor Concentrate Product and Services
 Table 112. Baxalta Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Baxalta Recent Developments/Updates
 Table 114. Baxalta Competitive Strengths & Weaknesses
 Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 116. Sanofi Major Business
 Table 117. Sanofi Recombinant Coagulation Factor Concentrate Product and Services
 Table 118. Sanofi Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Sanofi Competitive Strengths & Weaknesses
 Table 121. Biogen Basic Information, Manufacturing Base and Competitors
 Table 122. Biogen Major Business
 Table 123. Biogen Recombinant Coagulation Factor Concentrate Product and Services
 Table 124. Biogen Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Biogen Recent Developments/Updates
 Table 126. Biogen Competitive Strengths & Weaknesses
 Table 127. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 128. Pfizer Major Business
 Table 129. Pfizer Recombinant Coagulation Factor Concentrate Product and Services
 Table 130. Pfizer Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Pfizer Recent Developments/Updates
 Table 132. Pfizer Competitive Strengths & Weaknesses
 Table 133. Novo Disk Basic Information, Manufacturing Base and Competitors
 Table 134. Novo Disk Major Business
 Table 135. Novo Disk Recombinant Coagulation Factor Concentrate Product and Services
 Table 136. Novo Disk Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Novo Disk Recent Developments/Updates
 Table 138. Novo Disk Competitive Strengths & Weaknesses
 Table 139. Baxter Basic Information, Manufacturing Base and Competitors
 Table 140. Baxter Major Business
 Table 141. Baxter Recombinant Coagulation Factor Concentrate Product and Services
 Table 142. Baxter Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Baxter Recent Developments/Updates
 Table 144. Baxter Competitive Strengths & Weaknesses
 Table 145. Wyeth Basic Information, Manufacturing Base and Competitors
 Table 146. Wyeth Major Business
 Table 147. Wyeth Recombinant Coagulation Factor Concentrate Product and Services
 Table 148. Wyeth Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Wyeth Recent Developments/Updates
 Table 150. Wyeth Competitive Strengths & Weaknesses
 Table 151. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
 Table 152. Beijing Tiantan Biological Products Major Business
 Table 153. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product and Services
 Table 154. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Beijing Tiantan Biological Products Recent Developments/Updates
 Table 156. Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
 Table 157. SHANGHAI RAAS Basic Information, Manufacturing Base and Competitors
 Table 158. SHANGHAI RAAS Major Business
 Table 159. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product and Services
 Table 160. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 161. SHANGHAI RAAS Recent Developments/Updates
 Table 162. SHANGHAI RAAS Competitive Strengths & Weaknesses
 Table 163. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
 Table 164. Taibang Biologic Group Major Business
 Table 165. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product and Services
 Table 166. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 167. Taibang Biologic Group Recent Developments/Updates
 Table 168. Taibang Biologic Group Competitive Strengths & Weaknesses
 Table 169. HUALAN BIOLOGICAL ENGINEERING Basic Information, Manufacturing Base and Competitors
 Table 170. HUALAN BIOLOGICAL ENGINEERING Major Business
 Table 171. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product and Services
 Table 172. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 173. HUALAN BIOLOGICAL ENGINEERING Recent Developments/Updates
 Table 174. HUALAN BIOLOGICAL ENGINEERING Competitive Strengths & Weaknesses
 Table 175. Green Cross Basic Information, Manufacturing Base and Competitors
 Table 176. Green Cross Major Business
 Table 177. Green Cross Recombinant Coagulation Factor Concentrate Product and Services
 Table 178. Green Cross Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 179. Green Cross Recent Developments/Updates
 Table 180. Green Cross Competitive Strengths & Weaknesses
 Table 181. Global Key Players of Recombinant Coagulation Factor Concentrate Upstream (Raw Materials)
 Table 182. Global Recombinant Coagulation Factor Concentrate Typical Customers
 Table 183. Recombinant Coagulation Factor Concentrate Typical Distributors


List of Figures
 Figure 1. Recombinant Coagulation Factor Concentrate Picture
 Figure 2. World Recombinant Coagulation Factor Concentrate Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Recombinant Coagulation Factor Concentrate Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Recombinant Coagulation Factor Concentrate Production (2019-2030) & (K Units)
 Figure 5. World Recombinant Coagulation Factor Concentrate Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2019-2030)
 Figure 7. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2019-2030)
 Figure 8. North America Recombinant Coagulation Factor Concentrate Production (2019-2030) & (K Units)
 Figure 9. Europe Recombinant Coagulation Factor Concentrate Production (2019-2030) & (K Units)
 Figure 10. China Recombinant Coagulation Factor Concentrate Production (2019-2030) & (K Units)
 Figure 11. Japan Recombinant Coagulation Factor Concentrate Production (2019-2030) & (K Units)
 Figure 12. Recombinant Coagulation Factor Concentrate Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 15. World Recombinant Coagulation Factor Concentrate Consumption Market Share by Region (2019-2030)
 Figure 16. United States Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 17. China Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 18. Europe Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 19. Japan Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 22. India Recombinant Coagulation Factor Concentrate Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Recombinant Coagulation Factor Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Coagulation Factor Concentrate Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Coagulation Factor Concentrate Markets in 2023
 Figure 26. United States VS China: Recombinant Coagulation Factor Concentrate Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Recombinant Coagulation Factor Concentrate Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Recombinant Coagulation Factor Concentrate Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2023
 Figure 30. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2023
 Figure 32. World Recombinant Coagulation Factor Concentrate Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Type in 2023
 Figure 34. 250 IU
 Figure 35. 500 IU
 Figure 36. 1000 IU
 Figure 37. 2000 IU
 Figure 38. World Recombinant Coagulation Factor Concentrate Production Market Share by Type (2019-2030)
 Figure 39. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Type (2019-2030)
 Figure 40. World Recombinant Coagulation Factor Concentrate Average Price by Type (2019-2030) & (US$/Unit)
 Figure 41. World Recombinant Coagulation Factor Concentrate Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 42. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Application in 2023
 Figure 43. Hopistial
 Figure 44. Clinic
 Figure 45. Others
 Figure 46. World Recombinant Coagulation Factor Concentrate Production Market Share by Application (2019-2030)
 Figure 47. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Application (2019-2030)
 Figure 48. World Recombinant Coagulation Factor Concentrate Average Price by Application (2019-2030) & (US$/Unit)
 Figure 49. Recombinant Coagulation Factor Concentrate Industry Chain
 Figure 50. Recombinant Coagulation Factor Concentrate Procurement Model
 Figure 51. Recombinant Coagulation Factor Concentrate Sales Model
 Figure 52. Recombinant Coagulation Factor Concentrate Sales Channels, Direct Sales, and Distribution
 Figure 53. Methodology
 Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
Beijing Tiantan Biological Products
SHANGHAI RAAS
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
Green Cross

Related Reports

Global Recombinant Coagulation Factor Concentrate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Coagulation Factor Concentrate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

date 22 Jan 2023

date Pharma & Healthcare

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Recombinant Coagulation Factor Concentrate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Coagulation Factor Concentrate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 19 Nov 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Coagulation Factor Concentrate market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Recombinant Coagulation Factor Concentrate

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>